The Innovation in Pediatric Drugs Act of 2025 aims to amend the Federal Food, Drug, and Cosmetic Act to improve the investigation of molecularly targeted drugs for pediatric cancer. It ensures that drug companies fulfill pediatric study requirements and outlines procedures...
Simple Explanation
The Innovation in Pediatric Drugs Act of 2025 is about making sure medicine for kids with cancer is researched and tested just like medicine for grown-ups, so it's safe and works well for them too. It also talks about how there should be money to help study these medicines and what happens if the companies don't follow the rules.